Literature DB >> 32965556

Transcatheter or surgical aortic valve implantation in chronic dialysis patients: a German Aortic Valve Registry analysis.

Gloria Färber1, Sabine Bleiziffer2, Torsten Doenst3,4, Dimitra Bon5,6, Andreas Böning7, Helge Weiler8, Eva Herrmann5,6, Christian Frerker9, Andreas Beckmann10, Helge Möllmann11, Stephan Ensminger12, Raffi Bekeredjian13, Thomas Walther14, Wolfgang Harringer15, Hugo A Katus16, Christian W Hamm17, Friedhelm Beyersdorf18, Timm Bauer7, Stephan Fichtlscherer8.   

Abstract

OBJECTIVES: The aim of this study was to compare outcomes of transcatheter and surgical aortic valve implantation in chronic dialysis patients with aortic valve stenosis (AS).
BACKGROUND: Chronic dialysis patients undergoing heart valve surgery are at higher risk for morbidity and mortality. Whether interventional techniques can reduce this risk is unclear because dialysis patients have thus far been excluded from randomized trials.
METHODS: Chronic dialysis patients with AS enrolled in the German Aortic Valve Registry (GARY) between 2012 and 2015 were analyzed to compare transcatheter aortic valve implantation (TAVI n = 661) with surgical aortic valve replacement (SAVR n = 457). Propensity scores for inverse probability of treatment weighting (IPTW) were used to adjust the comparison of the two treatment groups for potential confounders.
RESULTS: TAVI patients were older (78 ± 7.3 vs. 69 ± 10.2 years, p < 0.01, unadjusted) and had more comorbidities. Mortality at 1 year was the same (TAVI: 33.4% vs. SAVR 35.0%, p = 0.72, IPTW-adjusted) while it was lower with TAVI at 30 days (8.6% vs. 15.0%, p = 0.02, IPTW-adjusted). TAVI patients required more pacemaker implantation and showed more aortic regurgitation. SAVR patients required more blood transfusions and had longer hospital stay. Diabetes mellitus, atrial fibrillation, previous PCI, urgent procedure and EuroSCORE were associated with elevated 30-day mortality. Atrial fibrillation and older age were independent risk factor of 1-year mortality in both groups.
CONCLUSIONS: Chronic dialysis patients with AS undergoing TAVI or SAVR had the same 1-year mortality, although survival at 30 days was better with TAVI. These results suggest that TAVI may improve peri-procedural outcomes.

Entities:  

Keywords:  Aortic valve; Dialysis; SAVR; TAVI

Year:  2020        PMID: 32965556     DOI: 10.1007/s00392-020-01717-7

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  32 in total

1.  Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis.

Authors:  Vinod H Thourani; Susheel Kodali; Raj R Makkar; Howard C Herrmann; Mathew Williams; Vasilis Babaliaros; Richard Smalling; Scott Lim; S Chris Malaisrie; Samir Kapadia; Wilson Y Szeto; Kevin L Greason; Dean Kereiakes; Gorav Ailawadi; Brian K Whisenant; Chandan Devireddy; Jonathon Leipsic; Rebecca T Hahn; Philippe Pibarot; Neil J Weissman; Wael A Jaber; David J Cohen; Rakesh Suri; E Murat Tuzcu; Lars G Svensson; John G Webb; Jeffrey W Moses; Michael J Mack; D Craig Miller; Craig R Smith; Maria C Alu; Rupa Parvataneni; Ralph B D'Agostino; Martin B Leon
Journal:  Lancet       Date:  2016-04-03       Impact factor: 79.321

Review 2.  2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Lee A Fleisher; Hani Jneid; Michael J Mack; Christopher J McLeod; Patrick T O'Gara; Vera H Rigolin; Thoralf M Sundt; Annemarie Thompson
Journal:  Circulation       Date:  2017-03-15       Impact factor: 29.690

3.  Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial.

Authors:  Hans Gustav Hørsted Thyregod; Daniel Andreas Steinbrüchel; Nikolaj Ihlemann; Henrik Nissen; Bo Juel Kjeldsen; Petur Petursson; Yanping Chang; Olaf Walter Franzen; Thomas Engstrøm; Peter Clemmensen; Peter Bo Hansen; Lars Willy Andersen; Peter Skov Olsen; Lars Søndergaard
Journal:  J Am Coll Cardiol       Date:  2015-03-15       Impact factor: 24.094

4.  Outcomes of Transcatheter and Surgical Aortic Valve Replacement in Patients on Maintenance Dialysis.

Authors:  Fahad Alqahtani; Sami Aljohani; Khaled Boobes; Elad Maor; Assem Sherieh; Charanjit S Rihal; David R Holmes; Mohamad Alkhouli
Journal:  Am J Med       Date:  2017-06-14       Impact factor: 4.965

5.  2017 ESC/EACTS Guidelines for the management of valvular heart disease.

Authors:  Volkmar Falk; Helmut Baumgartner; Jeroen J Bax; Michele De Bonis; Christian Hamm; Per Johan Holm; Bernard Iung; Patrizio Lancellotti; Emmanuel Lansac; Daniel Rodriguez Muñoz; Raphael Rosenhek; Johan Sjögren; Pilar Tornos Mas; Alec Vahanian; Thomas Walther; Olaf Wendler; Stephan Windecker; Jose Luis Zamorano
Journal:  Eur J Cardiothorac Surg       Date:  2017-10-01       Impact factor: 4.191

6.  Evolutive aortic stenosis in hemodialysis patients: analysis of risk factors.

Authors:  P Ureña; M C Malergue; B Goldfarb; P Prieur; C Guédon-Rapoud; M Pétrover
Journal:  Nephrologie       Date:  1999

7.  Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients.

Authors:  Michael J Reardon; Nicolas M Van Mieghem; Jeffrey J Popma; Neal S Kleiman; Lars Søndergaard; Mubashir Mumtaz; David H Adams; G Michael Deeb; Brijeshwar Maini; Hemal Gada; Stanley Chetcuti; Thomas Gleason; John Heiser; Rüdiger Lange; William Merhi; Jae K Oh; Peter S Olsen; Nicolo Piazza; Mathew Williams; Stephan Windecker; Steven J Yakubov; Eberhard Grube; Raj Makkar; Joon S Lee; John Conte; Eric Vang; Hang Nguyen; Yanping Chang; Andrew S Mugglin; Patrick W J C Serruys; Arie P Kappetein
Journal:  N Engl J Med       Date:  2017-03-17       Impact factor: 91.245

8.  Trends and Outcomes of Aortic Valve Replacement in Patients With End-Stage Renal Disease on Hemodialysis.

Authors:  Sami Aljohani; Fahad Alqahtani; Ahmad Almustafa; Khaled Boobes; Sujal Modi; Mohamad Alkhouli
Journal:  Am J Cardiol       Date:  2017-08-04       Impact factor: 2.778

9.  Calcific aortic stenosis: a complication of chronic uraemia.

Authors:  E R Maher; M Pazianas; J R Curtis
Journal:  Nephron       Date:  1987       Impact factor: 2.847

10.  US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Authors:  Rajiv Saran; Bruce Robinson; Kevin C Abbott; Lawrence Y C Agodoa; Nicole Bhave; Jennifer Bragg-Gresham; Rajesh Balkrishnan; Xue Dietrich; Ashley Eckard; Paul W Eggers; Abduzhappar Gaipov; Daniel Gillen; Debbie Gipson; Susan M Hailpern; Yoshio N Hall; Yun Han; Kevin He; William Herman; Michael Heung; Richard A Hirth; David Hutton; Steven J Jacobsen; Yan Jin; Kamyar Kalantar-Zadeh; Alissa Kapke; Csaba P Kovesdy; Danielle Lavallee; Janet Leslie; Keith McCullough; Zubin Modi; Miklos Z Molnar; Maria Montez-Rath; Hamid Moradi; Hal Morgenstern; Purna Mukhopadhyay; Brahmajee Nallamothu; Danh V Nguyen; Keith C Norris; Ann M O'Hare; Yoshitsugu Obi; Christina Park; Jeffrey Pearson; Ronald Pisoni; Praveen K Potukuchi; Panduranga Rao; Kaitlyn Repeck; Connie M Rhee; Jillian Schrager; Douglas E Schaubel; David T Selewski; Sally F Shaw; Jiaxiao M Shi; Monica Shieu; John J Sim; Melissa Soohoo; Diane Steffick; Elani Streja; Keiichi Sumida; Manjula K Tamura; Anca Tilea; Lan Tong; Dongyu Wang; Mia Wang; Kenneth J Woodside; Xin Xin; Maggie Yin; Amy S You; Hui Zhou; Vahakn Shahinian
Journal:  Am J Kidney Dis       Date:  2018-03       Impact factor: 8.860

View more
  1 in total

1.  Propensity matched comparison of TAVI and SAVR in intermediate-risk patients with severe aortic stenosis and moderate-to-severe chronic kidney disease: a subgroup analysis from the German Aortic Valve Registry.

Authors:  Stephan Fichtlscherer; Thomas Walther; Silvia Mas-Peiro; Gloria Faerber; Dimitra Bon; Eva Herrmann; Timm Bauer; Sabine Bleiziffer; Raffi Bekeredjian; Andreas Böning; Christian Frerker; Andreas Beckmann; Helge Möllmann; Stephan Ensminger; Christian W Hamm; Friedhelm Beyersdorf
Journal:  Clin Res Cardiol       Date:  2022-09-08       Impact factor: 6.138

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.